Clinical Trials Browser

Phase 2 × Histiocytoma, Malignant Fibrous × sintilimab × Clear all

NCT05017103 2024-12-11

Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study

Phase 2 Terminated

6 enrolled 9 charts

Histiocytoma, Malignant Fibrous